IL6 and atherosclerosis: The elevated levels of inflammatory factors such as tumor necrosis factor -α (TNF-α) and interleukin-6 (IL-6) in patients with T2DM can activate vascular endothelial cells, promote the expression of adhesion molecules, mediate the adhesion and migration of white blood cells, and accelerate the process of atherosclerosis (20).